Related Experiment Videos
Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders
1Department of Nuclear Medicine, Seoul National University Hospital, Korea.
Summary
Bone marrow immunoscintigraphy using technetium-99m-labeled antigranulocyte antibody (anti-NCA-95) effectively visualizes hematologic disorders. This imaging method shows abnormal antibody uptake in conditions like aplastic anemia and leukemia, aiding diagnosis.
Area of Science:
- Nuclear medicine
- Hematology
- Medical imaging
Background:
- Bone marrow is central to hematologic disorders.
- A suitable bone marrow imaging technique is needed.
- Immunoscintigraphy offers a potential solution.
Purpose of the Study:
- To evaluate bone marrow immunoscintigraphy using 99mTc-labeled antigranulocyte antibody (anti-NCA-95).
- To assess its utility in patients with various hematologic disorders.
Main Methods:
- 31 patients with hematologic disorders underwent bone marrow imaging.
- Intravenous injection of 99mTc-labeled anti-NCA-95 antibody.
- Bone marrow images acquired 4 hours post-injection; uptake ratios calculated.
Main Results:
- Aplastic anemia patients showed varied uptake patterns, often decreased compared to controls.
- Myelodysplastic syndrome and leukemia patients displayed irregular or decreased uptake.
- Antibody uptake correlated with peripheral blood cell counts.
Conclusions:
- Bone marrow immunoscintigraphy with antigranulocyte antibody is a valuable tool.
- It aids in assessing bone marrow status in diverse hematologic conditions.